← BioNTech SE
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $61.6m | $127.6m | $108.6m | $482.3m | $19.0b | $17.3b | $3.8b | $2.8b | $2.9b | |
| Revenue From Interest | — | $2.0m | $1.8m | $1.6m | $1.5m | $48.5m | $357.6m | $437.6m | — | |
| Cost of Goods and Services Sold | ($9.3m) | $13.7m | $17.4m | $59.3m | $2.9b | $3.0b | $599.8m | $541.3m | $641.8m | |
| Cost of sales | ($9.3m) | ($13.7m) | ($17.4m) | ($59.3m) | ($2.9b) | ($3.0b) | ($599.8m) | ($541.3m) | ($641.8m) | |
| Cost Of Revenue | ($9.3m) | $13.7m | $17.4m | $59.3m | $2.9b | $3.0b | $599.8m | $541.3m | $641.8m | |
| Reconciled Cost Of Revenue | ($9.3m) | $13.7m | $17.4m | $59.3m | $2.9b | $3.0b | $599.8m | $541.3m | $641.8m | |
| Gross Profit | $52.3m | $113.9m | $91.2m | $423.0m | $16.1b | $14.3b | $3.2b | $2.2b | $2.2b | |
| Research and development | — | $143.0m | $226.5m | $645.0m | $949.2m | $1.5b | $1.8b | $2.3b | $2.1b | |
| Operating expenses: | ||||||||||
| Other operating expenses | ($288k) | ($720k) | ($739k) | ($2.4m) | ($94.4m) | ($407.0m) | ($293.0m) | ($811.5m) | ($1.1b) | |
| Additional Financial Items | ||||||||||
| General and administrative | — | $26.3m | $45.5m | $94.0m | $285.8m | $484.7m | $495.0m | $531.1m | $514.4m | |
| Applicable Tax Rate | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Average Effective Tax Rate | — | — | — | — | $0 | $0 | $0 | $0 | ($0) | |
| Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | — | — | — | — | — | — | — | — | $57.2m | |
| Depreciation Right of Use Assets | — | $2.8m | $4.7m | $6.3m | $29.0m | $58.8m | $45.2m | $45.6m | $42.7m | |
| Finance Income | $2.1m | $8.0m | $4.1m | $1.6m | $67.7m | $330.3m | $519.6m | $664.0m | $423.9m | |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | — | — | — | — | — | — | — | — | $500k | |
| Other Income | — | — | — | — | — | — | — | — | $103.1m | |
| Profit Loss Attributable To Noncontrolling Interests | — | ($243k) | ($116k) | — | $0 | — | — | — | — | |
| Profit Loss Attributable To Owners Of Parent | ($85.7m) | ($48.0m) | ($179.1m) | $15.2m | $10.3b | $9.4b | $930.3m | ($665.3m) | ($1.1b) | |
| Profit Loss Before Tax | ($85.9m) | ($47.7m) | ($179.4m) | ($145.8m) | $15.0b | $13.0b | $1.2b | ($677.7m) | ($1.1b) | |
| Profit Loss From Operating Activities | ($61.3m) | ($53.9m) | ($181.5m) | ($82.4m) | $15.3b | $12.6b | $690.4m | ($1.3b) | ($1.4b) | |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | — | ($84k) | — | — | — | — | — | — | — | |
| Operating profit / (loss) | ($61.3m) | ($53.9m) | ($181.5m) | ($82.4m) | $15.3b | $12.6b | $690.4m | ($1.3b) | ($1.4b) | |
| Income taxes | ($45k) | ($600k) | $268k | $161.0m | ($4.8b) | ($3.5b) | ($255.8m) | $12.4m | ($85.3m) | |
| Net profit / (loss) | ($86.0m) | ($48.3m) | ($179.2m) | $15.2m | $10.3b | $9.4b | $930.3m | ($665.3m) | ($1.1b) | |
| Profit attributable to ordinary equity holders of the parent for basic earnings | ($85.7m) | ($48.0m) | ($179.1m) | $15.2m | $10.3b | $9.4b | $930.3m | ($665.3m) | ($1.1b) | |
| Non-controlling interests | ($297k) | ($243k) | ($116k) | $0 | $0 | — | — | — | — | |
| Diluted EPS | ($0.51) | ($0.25) | ($0.85) | $0.06 | $39.63 | $37.77 | $3.83 | ($2.77) | ($4.70) | |
| Diluted NI Availto Com Stockholders | ($85.7m) | ($48.0m) | ($179.1m) | $15.2m | $10.3b | $9.4b | $930.3m | ($665.3m) | ($1.1b) | |
| Gain On Sale Of Security | — | — | — | — | — | $672.2m | $318.8m | $710.5m | $383.4m | |
| Insurance And Claims | — | — | — | — | $30.4m | $21.3m | — | — | — | |
| Interest Income | — | $2.0m | $1.8m | $1.6m | $1.5m | $48.5m | $357.6m | $437.6m | — | |
| Interest Income Non Operating | — | $2.0m | $1.8m | $1.6m | $1.5m | $48.5m | $357.6m | $437.6m | — | |
| Net Income From Continuing And Discontinued Operation | ($85.7m) | ($48.0m) | ($179.1m) | $15.2m | $10.3b | $9.4b | $930.3m | ($665.3m) | ($1.1b) | |
| Net Income From Continuing Operation Net Minority Interest | ($85.7m) | ($48.0m) | ($179.1m) | $15.2m | $10.3b | $9.4b | $930.3m | ($665.3m) | ($1.1b) | |
| Net Interest Income | — | — | — | — | — | ($18.9m) | ($7.5m) | ($17.2m) | ($12.6m) | |
| Normalized EBITDA | — | — | — | — | — | $12.4b | $1.1b | ($411.7m) | ($256.3m) | |
| Normalized Income | — | — | — | — | — | $8.9b | $681.0m | ($713.3m) | ($822.1m) | |
| Other Gand A | — | — | — | — | — | $481.7m | $524.4m | $644.8m | $588.2m | |
| Other Special Charges | — | — | — | — | — | $3.0m | $29.4m | $657.4m | $789.5m | |
| Reconciled Depreciation | — | — | — | — | — | $123.3m | $183.4m | $298.0m | $382.8m | |
| Restructuring And Mergern Acquisition | — | — | — | — | ($2.2m) | — | $0 | $0 | ($15.0m) | |
| Salaries And Wages | — | — | — | — | $90.5m | $153.7m | — | — | — | |
| Selling General And Administration | — | — | — | — | — | $541.2m | $587.1m | $712.7m | $698.2m | |
| Special Income Charges | — | — | — | — | — | ($3.0m) | ($800k) | ($661.6m) | ($780.9m) | |
| Tax Effect Of Unusual Items | — | — | — | — | — | $182.0m | $68.7m | $880k | ($83.5m) | |
| Tax Provision | — | $600k | ($268k) | ($161.0m) | $4.8b | $3.5b | $255.8m | ($12.4m) | $85.3m | |
| Tax Rate For Calcs | — | — | — | — | — | $0 | $0 | $0 | $0 | |
| Write Off | — | — | — | — | — | — | $800k | $4.2m | $6.4m | |
| Net Foreign Exchange Loss | — | — | — | $42.6m | $0 | $0 | $16.0m | $0 | $48.4m | |
| Total Unusual Items | — | — | — | — | — | $669.2m | $318.0m | $48.9m | ($397.5m) | |
| Total Unusual Items Excluding Goodwill | — | — | — | — | — | $669.2m | $318.0m | $48.9m | ($397.5m) | |
| Pre-Tax Income | ($85.9m) | ($47.7m) | ($179.4m) | ($145.8m) | $15.0b | $13.0b | $1.2b | ($677.7m) | ($1.1b) | |
| Net Income | ($85.7m) | ($48.0m) | ($179.1m) | $15.2m | $10.3b | $9.4b | $930.3m | ($665.3m) | ($1.1b) | |
| Net Income Continuous Operations | ($85.7m) | ($48.0m) | ($179.1m) | $15.2m | $10.3b | $9.4b | $930.3m | ($665.3m) | ($1.1b) | |
| Net Income Including Noncontrolling Interests | ($85.7m) | ($48.0m) | ($179.1m) | $15.2m | $10.3b | $9.4b | $930.3m | ($665.3m) | ($1.1b) | |
| Basic Earnings (Loss) Per Share | — | — | ($0.85) | $0.06 | $42.18 | $38.78 | $3.87 | ($2.77) | ($4.70) | |
| Diluted Earnings (Loss) Per Share | ($0.51) | ($0.25) | ($0.85) | $0.06 | $39.63 | $37.77 | $3.83 | ($2.77) | ($4.70) | |
| Basic Average Shares | — | — | — | — | — | $243.3m | $240.6m | $240.2m | $241.7m | |
| Diluted Average Shares | — | — | — | — | — | $249.8m | $242.7m | $240.2m | $241.7m | |
| Research and development expenses | ($85.5m) | ($143.0m) | ($226.5m) | ($645.0m) | ($949.2m) | ($1.5b) | ($1.8b) | ($2.3b) | ($2.1b) | |
| General and administrative expenses | ($23.5m) | ($26.3m) | ($45.5m) | ($94.0m) | ($285.8m) | ($484.7m) | ($495.0m) | ($531.1m) | ($514.4m) | |
| Current Tax Expense (Income) | — | — | — | $17k | $4.5b | $3.6b | $243.1m | ($2.3m) | $11.4m | |
| Deferred Tax Expense (Income) | — | — | — | ($161.0m) | $218.9m | ($109.9m) | $12.7m | ($10.1m) | $73.9m | |
| Deferred Tax Expense (Income) Recognised In Profit Or Loss | — | — | — | $161.0m | ($218.9m) | $109.9m | ($12.7m) | $80.0m | ($73.9m) | |
| Employee Benefits Expense | — | — | — | $179.4m | $378.8m | $605.5m | $698.6m | $931.2m | $1.0b | |
| Expense From Share-Based Payment Transactions With Employees | — | — | — | — | $93.7m | $108.0m | $51.4m | $100.9m | $106.3m | |
| Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used | — | $90k | $90k | $300k | $400k | — | — | — | — | |
| Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used | — | $431k | $442k | $875k | $9.1m | — | — | — | — | |
| Finance Costs | — | $48k | $326k | $62.9m | $305.1m | $18.9m | $23.9m | $27.4m | $69.8m | |
| Other Employee Expense | — | — | — | — | — | — | — | — | $57.0m | |
| Other Expenses | — | — | — | — | — | — | $7.9m | — | — | |
| Other Finance Cost | — | — | — | — | — | — | — | $12.6m | $7.2m | |
| Other Operating Income Expense | $2.3m | $4.7m | $2.0m | $250.5m | $598.4m | $815.3m | $105.0m | ($670.9m) | ($903.7m) | |
| Postemployment Benefit Expense Defined Benefit Plans | — | — | — | $761k | $1.2m | $2.1m | $4.1m | $3.5m | $4.7m | |
| Sales and marketing expenses | ($6.6m) | ($3.0m) | ($2.7m) | ($14.5m) | ($50.4m) | ($59.5m) | ($62.7m) | ($67.9m) | ($110.0m) | |
| Finance expenses | ($26.0m) | ($48k) | ($326k) | ($62.9m) | ($305.1m) | ($18.9m) | ($23.9m) | ($27.4m) | ($69.8m) | |
| Interest Expense | — | — | — | — | — | $18.9m | $7.5m | $16.9m | $14.2m | |
| Interest Expense On Lease Liabilities | — | $1.7m | $1.7m | $2.0m | $2.9m | $5.1m | $5.7m | $8.6m | $8.2m | |
| Income Tax Expense Continuing Operations | — | $600k | ($268k) | ($161.0m) | $4.8b | $3.5b | $255.8m | ($12.4m) | $85.3m | |
| General And Administrative Expense | — | — | — | — | — | $481.7m | $524.4m | $644.8m | $588.2m | |
| Interest Expense Non Operating | — | — | — | — | — | $18.9m | $7.5m | $16.9m | $14.2m | |
| Net Non Operating Interest Income Expense | — | — | — | — | — | ($18.9m) | ($7.5m) | ($17.2m) | ($12.6m) | |
| Operating Expense | — | — | — | — | — | $2.0b | $2.3b | $2.9b | $2.9b | |
| Other Income Expense | — | — | — | — | — | $669.2m | $318.0m | $48.9m | ($397.5m) | |
| Selling And Marketing Expense | — | — | — | — | — | $59.5m | $62.7m | $67.9m | $110.0m | |
| Total Expenses | — | — | — | — | — | $5.0b | $2.9b | $3.5b | $3.5b | |
| Total Other Finance Cost | — | — | — | — | — | $2.7m | $7.9m | $300k | ($1.6m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.